Mount Sinai Beth Israel President Susan Somerville, RN, personally thanked 12 hospital employees for delivering exemplary patient care at a “Dinner With the President” held Tuesday, July 21, in the 2 Dazian Boardroom, Petrie Campus. Ms. Somerville recounted that the employees had been singled out by grateful patients—through letters and emails—as especially “caring,” “professional,” “courteous,” “fantastic,” and “kind.” Ms. Somerville said of her guests: “Their warmth, love, and commitment to their patients make them people who will move our hospital into the future.” She plans to host similar dinners and breakfasts every quarter to honor outstanding employees.
On a crisp, clear Sunday morning in early June, a Mount Sinai Health System team of more than 100 strong participated in the 2015 Liver Life Walk at Hudson River Park. Among the enthusiastic participants who walked the three-mile course and raised more than $20,000 to support the American Liver Foundation was Jennifer Long, a patient at Mount Sinai’s Recanati/Miller Transplantation Institute. Read more
New York Eye and Ear Infirmary of Mount Sinai recently launched a “Story Time” program for pediatric patients, an initiative designed to ease their anxiety in the hospital waiting room and to acquaint them with best-selling books that also happen to have a medical-friendly theme: The Berenstain Bears Go to the Doctor, for example, and Magenta Gets Glasses from the “Blue’s Clues” series. “Story Time” occurs at two locations: the main hospital and the nearby Ear Institute.
Advances in cancer immunotherapy, a promising new area in cancer treatment that harnesses the body’s immune system or natural defenses to destroy cancer cells, are being led by Nina Bhardwaj, MD, PhD, Director of Immunotherapy, and Professor of Medicine (Hematology and Medical Oncology), at The Tisch Cancer Institute. Read more
The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has been named a National Cancer Institute (NCI)-designated Cancer Center, an honor reserved for an elite group of U.S. institutions committed to researching and treating cancer.
In conjunction with the NCI designation, The Tisch Cancer Institute received a five-year, $8.5 million grant to support research and the recruitment of top physicians and scientists. More than 50 of the nation’s leading cancer researchers have joined The Tisch Cancer Institute since it was established in 2008. Read more
Fifteen high school, college, and graduate students who aspire to careers in health care participated in recent internships throughout the Mount Sinai Health System. The initiative, which provides opportunities to students from groups underrepresented in health care, is supported by the Office for Diversity and Inclusion (ODI) in partnership with five local organizations: the Greater New York Hospital Association (GNYHA); All Stars Project, Inc.; Committee for Hispanic Children and Families; Prep for Prep; and YouthBridge-NY. Read more
Trailblazing neurogenetics researcher Alison M. Goate, DPhil, was presented with the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research during the 2015 Alzheimer’s Association International Conference® held recently in Washington, D.C. The award honors individuals who have made significant, fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. Dr. Goate, who has been studying the genetics of Alzheimer’s disease for more than 27 years, reported the first genetic mutation that causes an inherited form of Alzheimer’s and co-led a team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease. Dr. Goate is Professor of Neuroscience, Genetics and Genomic Sciences, and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai.
Eight specialties within the Mount Sinai Health System were ranked among the top 25 in the nation, according to the 2015-2016 U.S. News & World Report Best Hospitals rankings, released in July. The specialties included seven at The Mount Sinai Hospital: Cardiology/Heart Surgery; Diabetes/Endocrinology; Ear, Nose & Throat (ENT); Gastroenterology/GI Surgery; Geriatrics; Nephrology; Neurology/Neurosurgery; and the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai. Among the top 25, four specialties moved higher in the rankings between 2014 and 2015, led by Cardiology/Heart Surgery, which now stands at No. 7, up from No. 10; Gastroenterology/GI Surgery at No. 8, up from No. 9; Neurology/Neurosurgery at No. 14, up from No. 15; and Nephrology, which moved up to No. 23 from No. 47. Read more
A total of 241 physicians from the Mount Sinai Health System’s seven hospital campuses and an additional 34 physicians from Mount Sinai’s affiliated hospitals were represented in New York magazine’s recently released list of “Best Doctors in New York.” The 275 physicians represented 21 percent of the overall 1,282 area doctors on the 2015 list, available online and in the June 8-14, 2015, print edition. The list covers physicians from throughout the New York metropolitan region, including Connecticut and New Jersey. Read more
A protein that promotes abnormal growth in melanoma cells has been identified for the first time by a team of researchers led by Emily Bernstein, PhD, Associate Professor of Oncological Sciences, and Dermatology, at the Icahn School of Medicine at Mount Sinai.
The novel discovery that the H2A.Z.2 protein is highly expressed in melanoma, appears to turn on the cell cycle, and makes melanoma cells grow faster, could also lead to therapeutic strategies that serve to inhibit cell proliferation. The results of Dr. Bernstein’s study were published in the July 2, 2015, issue of Molecular Cell. Read more